C5 and COVID-19: Overactivation of the complement system may contribute to thrombotic events in COVID-19 patients through the generation of high levels of anaphylatoxins C3a and C5a, which bind to their respective receptors C3aR and C5aR on platelets, thereby resulting in platelet hyperactivation and thrombosis [47,48,49].